Clinical Trials Directory

Trials / Completed

CompletedNCT01772511

Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?

BrUOG 274: Do Patients Participating In Oncology Clinical Trials Understand the Informed Consent Form?

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Andrew Sch umacher · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess patients' understanding of clinical trials and to help researchers understand which areas of the informed consent need better explanation for future cancer clinical trial patients.

Detailed description

Obtaining informed consent as part of a clinical study is a cornerstone of current day medical ethics; however, this has not always been the case. The development of the informed consent has been necessitated out of abuses committed in the name of medicine. Informed consents have become increasing lengthy and complex. It is not unusual for an Oncology Clinical Research informed consent to be greater than 20 pages. Investigators will utilize the QuIC-A survey to evaluate patient understanding of the basic elements of informed consent required by federal regulations. The QuIC-A survey has been condensed from 20 questions to 14 questions by eliminating the 6 phase specific questions. The remaining 14 questions are designed irrespective of phase and address the basic elements of informed consent. Investigators hypothesize that as informed consents have become more lengthy and complicated, in part due to required regulatory language and legal clauses inserted to protect the institution performing research, patient comprehension of the basic elements of informed consent has been hindered.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuestionnaireAll patients entering on this trial will have been enrolled on an oncology clinical trial and are receiving active anti-cancer treatment on that study.

Timeline

Start date
2012-03-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2013-01-21
Last updated
2015-01-27

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01772511. Inclusion in this directory is not an endorsement.